戻る
Lexeo Therapeutics Shares Advance on FDA Accelerated Approval Pathway Progress for LX2006
戻る
株式ニュース
テーマ
Lexeo Therapeutics Shares Advance on FDA Accelerated Approval Pathway Progress for LX2006
Lexeo Therapeutics Shares Advance on FDA Accelerated Approval Pathway Progress for LX2006
Edgen Stock
·
Oct 07 2025, 19:47
共有先
共有先
リンクをコピー
ソース：
[1] Lexeo: Maintaining Buy Rating Based On FDA Accelerated Approval Feedback
[2] Lexeo's gene therapy for Friedreich ataxia shows promising results By Investing.com
[3] Lexeo Therapeutics (LXEO) Aims for Accelerated Approval with LX2006 - GuruFocus
Edgen Stock·Oct 07 2025, 19:47Edgen Stock·Oct 07 2025, 19:47
Edgen Stock·Oct 07 2025, 19:47